GLAXOSMITHKLINE PHARMACEUTICALS
Back to Cashflow Statement
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹903 Cr | ₹1,290 Cr | ₹582 Cr | ₹484 Cr | ₹811 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹903 Cr |
| Mar2025 | ₹1,290 Cr |
| Mar2024 | ₹582 Cr |
| Mar2023 | ₹484 Cr |
| Mar2022 | ₹811 Cr |
How is Cash Flow from Operating Activities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹903 Cr | -29.97 | |
| Mar2025 | ₹1,290 Cr | 121.63 | |
| Mar2024 | ₹582 Cr | 20.20 | |
| Mar2023 | ₹484 Cr | -40.27 | |
| Mar2022 | ₹811 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹46,288.6 Cr | 3.2% | 12.2% | 9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | 3.2% |
12.2% |
9% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses